SGC in the News

Explore our news articles and stay connected with the SGC.

Read about the latest breakthroughs, awards and ongoing work from the SGC. Discover how our work is making a global impact and driving forward the field of drug discovery. Interested in getting first the latest news from SGC?

 

New drug leads to treat toxoplasmosis unveiled by collaboration between Washington University, UCSF and the SGC

Toxoplasmosis is a parasitic disease caused by the apicomplexan protozoa Toxoplasma gondii and can pose a significant threat to immunocompromised individuals, e.g. those undergoing organ transplantation or chemotherapy and HIV/AIDS patients, who cannot fight back the infection and are thus…

SGC joins European Union Framework Programme 7 grant on Affinomics.

The SGC has been awarded more than 0.5 M Euro as part of a joint EU FP7 -Health grant: 'Protein Binders for Characterisation of Human Proteome Function: Generation, Validation, Application "Affinomics", which encompasses 15 participant labs in eight different European countries for 5 years.

PLoS Biology and MCP adopt iSee to enhance articles with interactive 3D molecular graphics

Two influential journals are now accepting and publishing articles that are enhanced using a unique platform known as iSee (interactive Structurally enhanced experience), developed in a collaboration between the SGC's Dr. Brian Marsden and Dr. Wen Hwa Lee, with Prof. Ruben Abagyan and his team…

Categories